JACKSONVILLE, Florida and DEERFIELD, ill., March 22, 2010/PRNewswire/--according to a recent discussion among the members of the American Association of Clinical Endocrinologists (AACE) and key opinion leaders, the confusion of diabetes care information on the Internet – some of them inaccurate or even erroneous – makes it difficult for patients and caregivers to find reliable information related to type 2 diabetes. As a result, AACE has announced, with the support of Takeda Pharmaceuticals North America, Inc. (Takeda), the future creation of an online resource, analysed and evaluated by medical experts. The tool will be available later this year.
"Inaccurate or incomplete Information can lead to unnecessary stress or confusion between patients with type 2 diabetes," said George Grunberger, M.D., founder and President, Diabetes Institute Grunberger, Bloomfield Hills, Michigan and Board member of AACE. "With the growing number of Americans living with type 2 diabetes and with so many features already available, we need to make it easier for healthcare professionals, patients and health professionals access resources respectable and reliable basis for decisions on treatment and care."
Recent statistics show that more than 79 percent of adults in the United States (USA) are online, of which almost 90% use the Internet to find health information. With approximately 26 million people with diabetes, including 90-95% with type 2 diabetes, this population of patients and their caregivers represent a large group of people seeking health information online. Still, research suggests that less than 20 per cent of resources for diabetes online contain reliable information specific to the type 2 diabetes.
AACE and Takeda will offer a compendium of existing, trusted resources specific for type 2 diabetes, divided into different categories (e.g. Management, lifestyle and tools) and reviewed by experts, to help health care professionals: a guide for patients and health professionals as they try to end the disorder of the many features available.
The AACE partnership with Takeda responds to the needs of health professionals, caregivers and patients with diabetes. This comprehensive resource will help people browsing the Internet and find useful and reliable online information relevant to them, "said Lawrence blonde, M.D., Director, Ochsner Diabetes Clinical Research Unit at Ochsner Medical Center in New Orleans, Louisiana and former member of the Board of Directors of AACE. "Auto-diabetes care is an essential component of diabetes management. In addition to diabetes self-management education team of health care, access to other educational resources specific to your needs, you can help empower patients to actively and effectively participate in their care. "
About type 2 Diabetes
Type 2 Diabetes is the most common form of diabetes and reached epidemic proportions in the United States nearly 26 million Americans currently live with diabetes and at least 7 million are unaware that they have. Type 2 diabetes is a chronic and progressive condition and patients should work with a health professional to manage and monitor their disease. In addition to diet and exercise, patients often need to take various medications to help manage the glucose control. Global health costs for treating and preventing diabetes and its complications were estimated at $ 376 billion in 2010. By 2030, this number to exceed US $ 490 billion.
The American Association of Clinical Endocrinologists (AACE)
AACE is a professional medical organization with over 6500 members in the United States and 91 countries. AACE Members are physicians who specialize in Endocrinology, diabetes and metabolism. For more information about AACE, visit the AACE Web site at www.aace.com, become a fan on Facebook at www.facebook.com/theaace or follow AACE on Twitter at www.twitter.com/theaace.
Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc.
Headquartered in Deerfield, ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global
Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and Gastroenterology treatments and looking to bring innovative products to patients through a pipeline that includes compounds in development for diabetes, cardiovascular disease, Gastroenterology, Neurology and other conditions. To learn more about these Takeda companies, visit www.tpna.com.
0 komentar:
Posting Komentar